FDA Gives Firms Hawking H1N1 Remedies Tighter Deadline To Comply
This article was originally published in The Tan Sheet
Executive SummaryFDA's threats of near-immediate action against firms selling products with claims of treating the 2009-H1N1 flu virus are the sign of a fleet-footed and serious agency, says a food and drug attorney
You may also be interested in...
Valeant picks up skin care OTCs from J&J; FDA finds ‘supplements’ making anti-meningitis claims; Capsugel supplies Mercola.com; investigation charge slows Omega Protein; Vitacost continues diversifying sales mix more news in brief.